AFFIMED

What this means for you

Registered since 23 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97594404

Registration number

7283748

Mark type

Design + words

Filed

16 Sept 2022

Published for opposition

07 Nov 2023

Registered

23 Jan 2024

Attorney of record

Shauna M. Wertheim

Goods and services

• Class 001 — Chemicals: Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for scientific laboratory and scientific experimentation purposes, in particular for conducting experimental assays, all of the foregoing other than for medical or veterinary purposes
• Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes, all used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations for medical or veterinary purposes and in the form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for medical or veterinary purposes and for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes
• Class 042 — Scientific and technological services: Scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy, in particular in the field of immuno-oncology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of virology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design and engineering design, all in the field of antiinfectives; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research, and design in the nature of new product design, all in the field of neurodegenerative diseases; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial analysis and research services, namely, industrial research in the field of pharmaceuticals

Owner

• Affimed GmbH, Mannheim, DE
• Affimed GmbH, Mannheim, DE
• Affimed GmbH, Mannheim, DE

Prior registrations

• Registration 6578739

Prosecution history

• 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 23 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
• 04 Jan 2024 — ASSIGNED TO EXAMINER
• 07 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 07 Nov 2023 — PUBLISHED FOR OPPOSITION
• 18 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 06 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 06 Oct 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 06 Oct 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 02 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 21 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 20 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 20 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 03 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 03 Jul 2023 — NON-FINAL ACTION E-MAILED